A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population.

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

March 8, 2024

Primary Completion Date

March 8, 2024

Study Completion Date

April 11, 2025

Conditions
Pruritus
Interventions
DRUG

HSK21542 tablet

once-daily

DRUG

Placebo

once-daily

All Listed Sponsors
lead

Xizang Haisco Pharmaceutical Co., Ltd

INDUSTRY